Takeda Pharmaceutical Co. Ltd. | Key People and Executives
Jean-Luc Butel
Independent Outside Director
Christophe Weber
President, CEO & Representative Director
Andrew S. Plump
Director, Chief Medical & Scientific Officer
Masato Iwasaki
Director & President-Japan Pharma Business Unit
Yasuhiko Yamanaka
Managing Director & Head-Globalization
Koji Hatsukawa
Independent Outside Director
Toshiyuki Shiga
Independent Outside Director
Michel Orsinger
Independent Outside Director
Emiko Higashi
Independent Outside Director
Yoshiaki Fujimori
Independent Outside Director
Shiro Kuniya
Independent Outside Director
Masahiro Sakane
Independent Outside Director
Christophe Weber
President, CEO & Representative Director
Costa Saroukos
Chief Financial Officer
Andrew S. Plump
Director, Chief Medical & Scientific Officer
Kenji Sawai
Manager-Personnel & Administration
Takashi Okubo
Global Head-Investor Relations & Global Finance
Masato Iwasaki
Director & President-Japan Pharma Business Unit
Shinji Ninomiya
Manager-Research & Development
Giles Platford
President-Europe & Canada
Iwaaki Taniguchi
Senior Manager-Finance
Yasuhiko Yamanaka
Managing Director & Head-Globalization
Satoru Takemoto
General Manager-Sales
Norimasa Takeda
Head-Consolidated Accounting
Haruhiko Hirate
Corporate Communications & Public Affairs Officer
David Osborne
Global Human Resources Officer & Executive Officer
Yoshihiro Nakagawa
Executive Officer & Global General Counsel
Koji Hatsukawa
Independent Outside Director
Jean-Luc Butel
Independent Outside Director
Toshiyuki Shiga
Independent Outside Director
Michel Orsinger
Independent Outside Director
Emiko Higashi
Independent Outside Director
Yoshiaki Fujimori
Independent Outside Director
Shiro Kuniya
Independent Outside Director
Masahiro Sakane
Independent Outside Director
Address |
4-1-1 Dosho-machi Osaka Osaka 540 Japan
|
Employees
|
- |
Website |
http://www.takeda.co.jp |
Updated |
07/08/2019 |
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. |